These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15794203)

  • 1. Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone.
    van Vollenhoven RF; Gunnarsson I; Welin-Henriksson E; Sundelin B; Osterborg A; Jacobson SH; Klareskog L
    Scand J Rheumatol; 2004; 33(6):423-7. PubMed ID: 15794203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
    Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
    Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome.
    Melander C; Sallée M; Trolliet P; Candon S; Belenfant X; Daugas E; Rémy P; Zarrouk V; Pillebout E; Jacquot C; Boffa JJ; Karras A; Masse V; Lesavre P; Elie C; Brocheriou I; Knebelmann B; Noël LH; Fakhouri F
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):579-87. PubMed ID: 19261822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
    Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
    Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy.
    Camous L; Melander C; Vallet M; Squalli T; Knebelmann B; Noël LH; Fakhouri F
    Am J Kidney Dis; 2008 Aug; 52(2):346-52. PubMed ID: 18572292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of therapy-resistant systemic lupus erythematosus with rituximab: report of a case and review of the literature.
    Van den Bergh B; Selleslag D; Boelaert JR; Matthys EG; Schurgers M; Vandecasteele S; De Vriese A
    Acta Clin Belg; 2005; 60(2):102-5. PubMed ID: 16082997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response.
    Jónsdóttir T; Zickert A; Sundelin B; Henriksson EW; van Vollenhoven RF; Gunnarsson I
    Rheumatology (Oxford); 2013 May; 52(5):847-55. PubMed ID: 23287364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
    Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
    Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of refractory lupus nephritis with a protocol including rituximab.
    Fra GP; Avanzi GC; Bartoli E
    Lupus; 2003; 12(10):783-7. PubMed ID: 14596429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
    Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of clinical deterioration in patients with lupus nephritis receiving rituximab.
    Manou-Stathopoulou S; Robson MG
    Lupus; 2016 Oct; 25(12):1299-306. PubMed ID: 27084027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
    Demircin G; Oner A; Erdoğan O; Delibaş A; Baysun S; Bülbül M; Bek K; Oksal A
    Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?
    Li EK; Tam LS; Zhu TY; Li M; Kwok CL; Li TK; Leung YY; Wong KC; Szeto CC
    Rheumatology (Oxford); 2009 Aug; 48(8):892-8. PubMed ID: 19478041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose rituximab in refractory lupus nephritis.
    Kotagiri P; Martin A; Hughes P; Becker G; Nicholls K
    Intern Med J; 2016 Aug; 46(8):899-901. PubMed ID: 27242250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the management of lupus nephritis: let the treatment fit the patient.
    Bertsias G; Boumpas DT
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD20 antibody treatment in refractory Class IV lupus nephritis.
    Carroll RP; Brown F; Kerr PG
    Nephrol Dial Transplant; 2007 Jan; 22(1):291-3. PubMed ID: 17095581
    [No Abstract]   [Full Text] [Related]  

  • 19. Lupus nephritis associated with CD20+ B-cell NHL.
    Gumber MR; Kute VB; Goplani KR; Shah PR; Vanikar AV; Trivedi HL
    J Assoc Physicians India; 2011 Aug; 59():520-3. PubMed ID: 21887914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.